Home » Stocks » QTRX

Quanterix Corporation (QTRX)

Stock Price: $46.96 USD -9.14 (-16.29%)
Updated May 10, 2021 4:00 PM EDT - Market closed
After-hours: $47.48 +0.52 (1.11%) May 10, 6:09 PM
Market Cap 1.71B
Revenue (ttm) 97.86M
Net Income (ttm) -30.02M
Shares Out 36.33M
EPS (ttm) -0.97
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 10
Last Price $46.96
Previous Close $56.10
Change ($) -9.14
Change (%) -16.29%
Day's Open 54.79
Day's Range 46.57 - 56.25
Day's Volume 556,467
52-Week Range 23.87 - 92.57

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it will release its fina...

1 week ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the appointme...

1 week ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced a webinar with leading industr...

2 weeks ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has a...

2 weeks ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its Simoa® technology has...

1 month ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its ultra-sensitive Simoa...

1 month ago - Business Wire

Since going public just over three years ago, Quanterix Corp. (NASDAQ:QTRX) shares have quadrupled to about $63. Recently, the Billerica, Massachusetts-based diagnostics company closed another public of...

Other stocks mentioned: PKI
2 months ago - GuruFocus

Quanterix Corporation (QTRX) delivered earnings and revenue surprises of -3.33% and 3.09%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced financial results for the fou...

2 months ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman, Chief Executive...

2 months ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it will release its fina...

2 months ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman, Chief Executiv...

2 months ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into an agreem...

2 months ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the closing of its previously...

3 months ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the pricing of its previously...

3 months ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it has commenced an unde...

3 months ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced Chairman, Chief Executive Off...

3 months ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today provided operational and preliminary fi...

3 months ago - Business Wire

Shares of Quanterix Corp. rallied nearly 10% in the extended session Monday after the life-sciences company said the Food and Drug Administration has issued an emergency use authorization for the compan...

3 months ago - Market Watch

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that the Food and Drug Adminis...

3 months ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its Chairman, Chief Exec...

4 months ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that the Food and Drug Admini...

4 months ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Appoints William Geist as Chief Operating Officer

5 months ago - Business Wire

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced Chairman, Chief Executive Off...

5 months ago - Business Wire

Quanterix Corporation's (QTRX) CEO Kevin Hrusovsky on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its Chairman, Chief Exec...

6 months ago - Business Wire

Quanterix: Still Bullish But Valuation Less Compelling

6 months ago - Seeking Alpha

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into a non-exc...

Other stocks mentioned: ABT
7 months ago - Business Wire

Quanterix's industry leading platform, which is highly levered to the growth in precision medicine, can detect protein biomarkers at significantly lower concentrations and at higher sensitivity vs compe...

7 months ago - Seeking Alpha

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the closing of its previously...

8 months ago - Business Wire

Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Quanterix (QTRX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

1 year ago - Zacks Investment Research

Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Quanterix Corp (QTRX) CEO Kevin Hrusovsky on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.

Other stocks mentioned: CGC, MDT
1 year ago - Zacks Investment Research

Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q1 2019 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

About QTRX

Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also provides SP-X instrument that is based on... [Read more...]

Industry
Medical Devices
IPO Date
Dec 7, 2017
Stock Exchange
NASDAQ
Ticker Symbol
QTRX
Full Company Profile

Financial Performance

In 2020, Quanterix's revenue was $86.38 million, an increase of 52.25% compared to the previous year's $56.73 million. Losses were -$31.53 million, -22.71% less than in 2019.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for Quanterix stock is "Strong Buy." The 12-month stock price forecast is 84.00, which is an increase of 78.88% from the latest price.

Price Target
$84.00
(78.88% upside)
Analyst Consensus: Strong Buy